A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Clinical trial NCT00207662 · COMPLETED
Trial details
- NCT number
- NCT00207662
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.